Shelly Pack
Family · Princeton, WVNPI 1629714761
Payments from drug & device makers
Across 202 payments — averaging $16.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$738
- Lilly USA, LLC$703
- AbbVie$393
- AstraZeneca$209
- Exact Sciences$206
- Merck$194
- plus $859 from 12 others
What the payments were for
- Food & beverage$3,301100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 50 | $738 |
| Lilly USA, LLC | 45 | $703 |
| AbbVie | 22 | $393 |
| AstraZeneca | 13 | $209 |
| Exact Sciences | 10 | $206 |
| Merck | 12 | $194 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $185 |
| Bayer | 11 | $181 |
| Boehringer Ingelheim | 7 | $151 |
| GSK | 8 | $137 |
| Mylan Specialty L.p. | 3 | $53 |
| Corium, LLC | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
| Electromed, Inc. | 1 | $21 |
| Hologic Sales And Service, LLC | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| Pfizer | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$120
How this compares
$3,301 in reported general payments places this provider in the 85th percentile of 1,507 family providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 18 | $18,311 |
| OzempicSemaglutide | 17 | $16,367 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $15,235 |
| JanuviaSitagliptin Phosphate | 12 | $13,057 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $9,149 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 40 | $1,036 |
| Pregabalin | 24 | $531 |
| Omeprazole | 15 | $307 |
| Lisinopril | 27 | $215 |
| Atorvastatin Calcium | 34 | $214 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 13 | $184 |
| Methylprednisolone | 25 | $176 |
| Metoprolol Succinate | 15 | $169 |
| Famotidine | 16 | $158 |
| Azithromycin | 28 | $121 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $151 | $18,31118 claims |
| Novo NordiskOzempic | $738 | $16,36717 claims |
| GSKTrelegy Ellipta | $137 | $15,23515 claims |
| MerckJanuvia | $194 | $13,05712 claims |
| AstraZenecaBreztri Aerosphere | $209 | $9,14913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,507 family providers in West Virginia.
Other family in Princeton
- Rhonda RayPrinceton$10K
- Tracy McKenziePrinceton$8K
- Angela AkersPrinceton$7K
- Jessica MarcusPrinceton$7K
- Sabrina HuffmanPrinceton$7K
- Ashley ComerCharleston$213K
- Dana CruseParkersburg$109K
- Sarah KnightCharleston$99K
- Star RoeBarboursville$55K
- Angela SettleCharleston$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.